Radioliganden-Therapie des metastasierten Prostatakarzinoms mit 177Lu-PSMA-617
- PMID: 28854467
- DOI: 10.1055/s-0043-118584
Radioliganden-Therapie des metastasierten Prostatakarzinoms mit 177Lu-PSMA-617
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Comment on
-
Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis.J Nucl Med. 2016 Sep;57(9):1334-8. doi: 10.2967/jnumed.116.173757. Epub 2016 Apr 7. J Nucl Med. 2016. PMID: 27056618
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources